INMED PHARMACEUTICALS INC. Capital Expenditure, Discontinued Operations
INMED PHARMACEUTICALS INC. (INM) reported Capital Expenditure, Discontinued Operations of $1.59 million for the 12-month period ending 2022-12-31, per its 10-Q filed 2023-02-17.
Discontinued › Notes
us-gaap:CapitalExpenditureDiscontinuedOperations · last filed 2023-02-17
- INMED PHARMACEUTICALS INC. capital expenditure, discontinued operations for fiscal 2022 was $2.15M.
| Period end | Capital Expenditure, Discontinued Operations 12 month |
|---|---|
| 2022-12-31 | $1.59M 10-Q · filed 2023-02-17 |
| 2022-09-30 | $1.63M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.15M 10-K · filed 2022-09-23 |
| 2022-03-31 | $3.21M 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |